PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, featuring promising progress throughout several clinical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, additional responsible alternative for therapeutic use, sign